Cyclin D1 gene amplification is highly homogeneous in breast cancer

Frequent amplifications and deletions of G1/S-phase transition genes, CCND1 and MYC in early breast cancers: A potential role in G1/S escape

(2017) L.B. Jensen et al.   Cancer Biomarkers

Molecular Differences between Ductal CarcinomaIn Situand Adjacent Invasive Breast Carcinoma: A Multiplex Ligation-Dependent Probe Amplification Study

(2015) Cathy B. Moelans et al.   Analytical Cellular Pathology

Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers

(2010) Andreas H. Marx et al.   HUMAN PATHOLOGY

Gene amplification in ductal carcinoma in situ of the breast

(2009) L. Burkhardt et al.   BREAST CANCER RESEARCH AND TREATMENT

The role of X-box binding protein-1 in tumorigenicity

(2009) A.N. Shajahan et al.   DRUG NEWS & PERSPECTIVES

HER-2 amplification is highly homogenous in gastric cancer

(2009) Andreas H. Marx et al.   HUMAN PATHOLOGY

A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases

(2009) Sara E. Monaco et al.   HUMAN PATHOLOGY

Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer

(2009) Lorenzo Daniele et al.   Journal of Thoracic Oncology

ERRγ Mediates Tamoxifen Resistance in Novel Models of Invasive Lobular Breast Cancer

(2008) Rebecca B. Riggins et al.   CANCER RESEARCH

Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab: A Fluorescent In situ Hybridization Study

(2008) N. Personeni et al.   CLINICAL CANCER RESEARCH

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

(2008) M. Rudas et al.   CLINICAL CANCER RESEARCH

Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen

(2008) Antoni Hurtado et al.   NATURE